News

Evofem's PHEXXI Receives UAE Marketing Approval from Pharma 1

Evofem's PHEXXI Receives UAE Marketing Approval from Pharma 1

Evofem's PHEXXI Submitted for UAE Marketing Approval

In an exciting development for women’s health, Evofem Biosciences, Inc. is moving forward with the marketing approval process of its innovative product PHEXXI in the UAE. This hormone-free contraceptive gel, known scientifically as lactic acid, citric acid, and potassium bitartrate, is designed to empower women by allowing them to take control of their reproductive health on their terms.

Pharma 1 Drug Store, a leading Emirati healthcare provider, has officially submitted an application to the Ministry of Health and Prevention (MOHAP) in the UAE. The company aims to commercialize PHEXXI effectively, indicating a strong commitment to addressing the contraceptive needs of women in the region.

Upcoming Launch Plans for PHEXXI

Pharma 1 Drug Store has plans to place a substantial launch order for PHEXXI, setting July 2025 as a milestone for initial quantities. Following this, the official commercial launch is anticipated in the first quarter of 2026. This timeline reflects a comprehensive strategy to ensure that women in the UAE can access effective contraception when they need it most.

CEO Insights on Market Strategy

Abdulwahab Atfah, CEO of Pharma 1, expressed optimism regarding the potential success of PHEXXI in the UAE market. According to market research, there is an increasing demand for hormone-free contraceptive methods in the UAE and neighboring regions. Atfah believes that healthcare professionals, including OB/GYNs, will welcome this product enthusiastically, recognizing its value for their patients.

“This moment marks a significant milestone in bringing PHEXXI to women outside of the United States,” stated Saundra Pelletier, CEO of Evofem. The company foresees a fruitful expansion of revenue through sales to Pharma 1 and the availability of PHEXXI for Emirati women seeking a non-systemic birth control option.

Pharma 1's Role in Distribution

Pharma 1 holds exclusive commercialization rights for PHEXXI across various Middle Eastern countries, including the UAE, Kuwait, Saudi Arabia, and Qatar, amongst others. This agreement places the responsibility on Pharma 1 for regulatory approvals, marketing, and distribution of PHEXXI, enabling the company to harness its expertise in navigating these crucial areas effectively.

The Need for Innovative Healthcare Solutions

Since its establishment, Pharma 1 has successfully met the healthcare needs of communities within the Gulf Cooperation Council (GCC). The company relies on solid scientific approaches and meaningful market research to guide its offerings, ensuring they evolve with the needs of the population.

PHEXXI: A Unique Contraceptive Option

PHEXXI stands apart as the first locally acting contraceptive gel that has gained approval from the U.S. Food and Drug Administration (FDA). Users can apply PHEXXI within a window of 60 minutes before intercourse using a pre-filled applicator. This product works without hormones, maintaining a normal vaginal microbiome that inherently resists sperm and certain pathogens.

About Evofem Biosciences

Evofem Biosciences, Inc. pledges to deliver groundbreaking solutions in women's sexual and reproductive health. The company is driven to meet unmet medical needs and currently markets two FDA-approved products: PHEXXI and SOLOSEC, an oral antibiotic used for treating bacterial vaginosis and trichomoniasis. The relaunch of SOLOSEC in late 2024 alongside PHEXXI illustrates Evofem’s continuous growth and commitment to enhancing women’s health options.

Frequently Asked Questions

What is PHEXXI?

PHEXXI is a hormone-free contraceptive gel that is applied before intercourse, working by maintaining a pH that resists sperm and some pathogens.

When is the planned commercial launch of PHEXXI in the UAE?

The commercial launch in the UAE is targeted for the first quarter of 2026, following a launch quantity order in July 2025.

Who is responsible for marketing PHEXXI in the UAE?

Pharma 1 Drug Store holds exclusive rights to market PHEXXI in the UAE and surrounding regions.

How does PHEXXI differ from traditional contraceptives?

PHEXXI is unique as it uses a non-hormonal mechanism to prevent pregnancy and can be used on demand as needed.

What are the benefits of PHEXXI for women in the UAE?

PHEXXI offers women a convenient, hormone-free option for contraception, aligning with growing preferences for non-systemic birth control methods.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI Era Redefines Media Collaboration Worldwide

Updated Category News Views 55

AI and the Changing Media Landscape Folks, let's talk about the new kid shaking up the block—artificial intelligence, yeah, AI. The 7th World Media Summit just rolled out a snazzy preview video fittingly dubbed "AI-Powered, Toward a Shared New Future." This ain't your run-of-the-mill teaser. It's a slick mix of live-action, old footage, and some AI-engineered visuals to...

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 150

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
Innovative Eyewear Powers Ahead with 51% Revenue Boost

Updated Category News Views 64

Big Gains and Bigger Moves Ahead Here's a bit of sunshine for your investment portfolio: Innovative Eyewear's third-quarter results are packing quite the punch, showing a strong 51% uptick in revenue year-over-year. If you've got a stake in NASDAQ:LUCY, pay close attention. This ain't just a flash in the pan; it's a consistent rise, marking their 13th consecutive quarter...

Continue Reading
Trimble's New Machine Control Tech Promises Big Gains

Updated Category News Views 43

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...

Continue Reading
Greenberg Traurig Expands Franchise Team with Tuneski

Updated Category News Views 87

DC’s Legal Landscape Shifts with Tuneski’s Move Greenberg Traurig's Washington, D.C., office just dialed it up a notch by bringing in Alexander Tuneski. A guy like this crossing the floor from DLA Piper is big news. This isn’t just any legal bean counter; with over 20 years under his belt, Tuneski knows franchise law like the back of his hand. And when you've been...

Continue Reading
Navigating Simultaneous Home Buy and Sell Strategies

Updated Category News Views 42

Juggling Two Housing Transactions You ever tried juggling chainsaws? That's what buying and selling your home at the same time can feel like. Selling First: Playing It Safe Some folks swear by selling their current home first, and there's good reason. It locks in your financial windfall, giving you a clear picture of your down payment and affordability. No more guessing...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 191

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 262

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Creality's Kid-Friendly AI 3D Printer Debuts at $329

Updated Category News Views 0

Creality Unpacks mBox for Young Innovators You squint at the market to find the next big thing, and here comes Creality tossing a fancy innovation into the ring. Meet the mBox—a kid-operated, AI-driven 3D printer. This little contraption is set to spark youthful imagination, not just buzz amongst hobbyist circles. They're rolling this out on TikTok Shop from November 9...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 154

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading

Top 5 Most Recently Viewed Articles

The Impressive Journey of RBC Bearings Stock Over 15 Years

Updated Category News Views 179

Unveiling the Growth of RBC Bearings RBC Bearings has shown a remarkable performance in the stock market over the last 15 years, outperforming the market by 6.2% annually. This impressive annualized return of 18.41% equates to a significant compound growth for shareholders. The Magnitude of Investment Returns For those investors who bought $1000 worth of RBC Bearings...

Continue Reading
Neugebauer's Town Hall: Fermi's Future Under Scrutiny

Updated Category News Views 32

Fermi's Shareholders Demand Answers: The Stage is Set There's nothing like an impending webinar showdown to light a fire under Fermi's management. Toby Neugebauer, who's not just any co-founder but the largest shareholder, is gearing up to host a Town Hall this June 30th. The absence of the Perrys—Rick and his son Griffin—is glaring, but that’s not stopping...

Continue Reading
Jeff Cook Real Estate Launches Innovative Home-Buying App

Updated Category News Views 105

Introducing a Game-Changing Real Estate App Jeff Cook Real Estate LPT Realty is transforming the home-buying experience with the launch of its innovative mobile app. This cutting-edge technology aims to enhance the way home buyers and sellers interact with the real estate market in South Carolina and North Carolina, emphasizing the company's commitment to superior...

Continue Reading
Middlefield Canadian Income PCC Sees Positive NAV Growth Trend

Updated Category News Views 160

Understanding the Net Asset Value of Middlefield Canadian Income PCC The exciting world of investment trusts often revolves around the performance of their net asset values (NAV). Middlefield Canadian Income PCC is no exception. With a focus on providing value to its investors, the company's NAV reflects its current standing in the market. Net Asset Value Insights As of a...

Continue Reading
Expanding Affordable Insulin Options Through Collaboration

Updated Category News Views 207

Enhancing Diabetes Care with New Insulin Collaboration Additional treatment options for the 38.4 million U.S. patients living with diabetes Biocon Biologics Ltd., a leading global biosimilars company, has expanded its collaboration with Civica, Inc. to introduce a new Insulin Glargine medicine. This innovative product aims to improve access to high-quality and affordable...

Continue Reading